Eton Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for ETON, and when can generic versions of ETON drugs launch?
ETON has two approved drugs.
There are three US patents protecting ETON drugs.
There are forty-four patent family members on ETON drugs in twenty-four countries and two supplementary protection certificates in two countries.
Summary for Eton
| International Patents: | 44 |
| US Patents: | 3 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
| PTAB Cases with Eton as petitioner: | See PTAB cases with Eton as petitioner |
Drugs and US Patents for Eton
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-003 | Sep 29, 2020 | RX | Yes | No | 9,675,559 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-001 | Sep 29, 2020 | RX | Yes | No | 9,675,559 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eton | BETAINE | betaine | FOR SOLUTION;ORAL | 210508-001 | Jan 28, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-003 | Sep 29, 2020 | RX | Yes | No | 9,717,740 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-002 | Sep 29, 2020 | RX | Yes | No | 9,675,559 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-001 | Sep 29, 2020 | RX | Yes | No | 9,649,280 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-002 | Sep 29, 2020 | RX | Yes | No | 9,649,280 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eton Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 2780003 | ⤷ Try a Trial |
| European Patent Office | 2978414 | ⤷ Try a Trial |
| Brazil | 112015028025 | ⤷ Try a Trial |
| Lithuania | 2978414 | ⤷ Try a Trial |
| South Korea | 20160011205 | ⤷ Try a Trial |
| Canada | 2854717 | ⤷ Try a Trial |
| Serbia | 60734 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eton Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
| 0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
